Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Frequently asked questions
What sector does Aida Pharmaceuticals Inc (AIDA) operate in?
Aida Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Aida Pharmaceuticals Inc (AIDA) current stock price?
As of the latest data, Aida Pharmaceuticals Inc stock price is $0.00, with a previous close of $0.00.
What is Aida Pharmaceuticals Inc (AIDA) current market capitalization?
Aida Pharmaceuticals Inc market cap is approximately 12.55 million.
Does Aida Pharmaceuticals Inc (AIDA) pay dividends?
No. Aida Pharmaceuticals Inc does not pay a dividend.
What is Aida Pharmaceuticals Inc (AIDA) beta (volatility) score?
Aida Pharmaceuticals Inc has a beta of 21.835, indicating very high volatility compared to the market.